| Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence B Russell, C Moss, G George, A Santaolalla, A Cope, S Papa, ... ecancermedicalscience 14, 2020 | 488 | 2020 |
| Impact of the COVID-19 pandemic on the mental health and well-being of UK healthcare workers J Gilleen, A Santaolalla, L Valdearenas, C Salice, M Fusté BJPsych open 7 (3), e88, 2021 | 132 | 2021 |
| Use of a handheld terahertz pulsed imaging device to differentiate benign and malignant breast tissue MR Grootendorst, AJ Fitzgerald, SGB De Koning, A Santaolalla, A Portieri, ... Biomedical Optics Express 8 (6), 2932-2945, 2017 | 93 | 2017 |
| Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ... European urology 75 (3), 523-531, 2019 | 72 | 2019 |
| The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date SM Bruinsma, L Zhang, MJ Roobol, CH Bangma, EW Steyerberg, ... BJU international 121 (5), 737-744, 2018 | 64 | 2018 |
| Tumor-infiltrating B lymphocyte profiling identifies IgG-biased, clonally expanded prognostic phenotypes in triple-negative breast cancer RJ Harris, A Cheung, JCF Ng, R Laddach, AM Chenoweth, S Crescioli, ... Cancer research 81 (16), 4290-4304, 2021 | 49 | 2021 |
| Association Between Vitamin D and Novel SARS-CoV-2 respiratory dysfunction–a scoping review of current evidence and its implication for COVID-19 pandemic A Santaolalla, K Beckmann, J Kibaru, D Josephs, M Van Hemelrijck, ... Frontiers in physiology 11, 564387, 2020 | 45 | 2020 |
| Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial J Zylstra, GP Whyte, K Beckmann, J Pate, A Santaolalla, L Gervais-Andre, ... British Journal of Sports Medicine 56 (7), 402-409, 2022 | 40 | 2022 |
| Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study S Sollie, DS Michaud, D Sarker, SN Karagiannis, DH Josephs, N Hammar, ... BMC cancer 19, 1-6, 2019 | 37 | 2019 |
| Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort A Essén, A Santaolalla, H Garmo, N Hammar, G Walldius, I Jungner, ... Cancer Causes & Control 30, 603-615, 2019 | 25 | 2019 |
| Adherence to active surveillance protocols for low-risk prostate cancer: results of the Movember foundation’s global action plan prostate cancer active surveillance initiative AA Kalapara, JFM Verbeek, D Nieboer, M Fahey, V Gnanapragasam, ... European urology oncology 3 (1), 80-91, 2020 | 23 | 2020 |
| Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer D Crawley, A Chandra, M Loda, C Gillett, P Cathcart, B Challacombe, ... BMc cancer 17, 1-12, 2017 | 22 | 2017 |
| Predicting biopsy outcomes during active surveillance for prostate cancer: external validation of the canary prostate active surveillance study risk calculators in five large … FJH Drost, D Nieboer, TM Morgan, PR Carroll, MJ Roobol, B Trock, ... European urology 76 (5), 693-702, 2019 | 20 | 2019 |
| Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes HJ Bax, J Chauhan, C Stavraka, A Santaolalla, G Osborn, A Khiabany, ... British Journal of Cancer 128 (2), 342-353, 2023 | 18 | 2023 |
| Antibodies as biomarkers for cancer risk: a systematic review MJ Monroy-Iglesias, S Crescioli, K Beckmann, N Le, SN Karagiannis, ... Clinical and Experimental Immunology 209 (1), 46-63, 2022 | 18 | 2022 |
| Real world evidence: a quantitative and qualitative glance at participant feedback from a free-response survey investigating experiences of a structured exercise intervention … L Fox, F Cahill, C Burgess, N Peat, S Rudman, J Kinsella, D Cahill, ... BioMed Research International 2017, 2017 | 18 | 2017 |
| King’s health partners’ prostate cancer biobank (KHP PCaBB) SR Saifuddin, W Devlies, A Santaolalla, F Cahill, G George, D Enting, ... BMC cancer 17, 1-8, 2017 | 16 | 2017 |
| Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance A Tomer, D Nieboer, MJ Roobol, A Bjartell, EW Steyerberg, D Rizopoulos, ... BJU international 127 (1), 96-107, 2021 | 14 | 2021 |
| Prostate cancer patients under active surveillance with a suspicious magnetic resonance imaging finding are at increased risk of needing treatment: results of the Movember … J Olivier, W Li, D Nieboer, J Helleman, M Roobol, V Gnanapragasam, ... European Urology Open Science 35, 59-67, 2022 | 13 | 2022 |
| ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI T Marsden, DJ Lomas, N McCartan, J Hadley, S Tuck, L Brown, A Haire, ... BMJ open 11 (9), e048144, 2021 | 13 | 2021 |
